Related references
Note: Only part of the references are listed.Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel
Alice K. Pau et al.
ANNALS OF INTERNAL MEDICINE (2021)
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
COVID-19 convalescent plasma composition and immunological effects in severe patients
Yeny Acosta-Ampudia et al.
JOURNAL OF AUTOIMMUNITY (2021)
Place of Death and End-of-Life Care Utilization among COVID-19 Decedents in a Massachusetts Health Care System
Isaac S. Chua et al.
JOURNAL OF PALLIATIVE MEDICINE (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
M. J. Joyner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19 A Systematic Review and Meta-analysis
Perrine Janiaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
COVID-19 convalescent plasma: Interim recommendations from the AABB
Claudia S. Cohn et al.
TRANSFUSION (2021)
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis
Samuel Pullan et al.
VACCINE (2021)
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Arturo Casadevall et al.
MBIO (2021)
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Robert Challen et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment
Jian Wu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial*
Elliott Bennett-Guerrero et al.
CRITICAL CARE MEDICINE (2021)
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19
Purbita Bandopadhyay et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Trends in COVID-19 Risk-Adjusted Mortality Rates
Leora Horwitz et al.
JOURNAL OF HOSPITAL MEDICINE (2021)
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
Jing Sun et al.
CELL (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Distribution in Place of Death for COVID-19-Related Mortality in the United States
Sarah Chuzi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
Liise-anne Pirofski et al.
MBIO (2020)
Convalescent plasma falls flat in first randomized trial
Cormac Sheridan
NATURE BIOTECHNOLOGY (2020)
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
Sean T. H. Liu et al.
NATURE MEDICINE (2020)
The FDA and the Importance of Trust
Lindsey R. Baden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Convalescent plasma is ineffective for covid-19 Lessons from the Placid Trial
Elizabeth B. Pathak
BMJ-BRITISH MEDICAL JOURNAL (2020)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Anup Agarwal et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients
Christel Faes et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients
Douglas Tremblay et al.
CANCER MEDICINE (2020)
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Min Seo Kim et al.
PLOS MEDICINE (2020)
The Assessment of Convalescent Plasma Efficacy against COVID-19
Arturo Casadevall et al.
MED (2020)
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
Yasmin Maor et al.
ECLINICALMEDICINE (2020)